Skip to main content
Clinical Trials/IRCT20180411039272N1
IRCT20180411039272N1
Recruiting
Phase 3

Comparison of the efficacy of oral, intravenous and topical Tranexamic acid in reducing bleeding after total knee arthroplasty

Arak University of Medical Sciences0 sites135 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Arak University of Medical Sciences
Enrollment
135
Status
Recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients undergoing total knee arthroplasty admitted in Amiralmoemenin and Valiasr hospital in Arak
  • Patients between 30 and 80 years old
  • Patient with ASA class1 and 2
  • Patients who have informed consent for presence in mentioned project
  • Patients who are operated by one surgeon
  • duration of operation time between 90 and 180 minutes

Exclusion Criteria

  • All Patients out rang of 30 to 80 years old
  • Lack of Informed consent
  • Patients with multiple surgeries
  • Patients who are sensitive to Tranexamic acid
  • Patients undergoing general anesthesia

Outcomes

Primary Outcomes

Not specified

Similar Trials